Title:
二重特異的融合タンパク質
Document Type and Number:
Japanese Patent JP6965311
Kind Code:
B2
Abstract:
Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair or regenerate damaged or diseased tissue. The bi-specific fusion proteins generally comprise: (a) a targeting polypeptide domain that binds to a target molecule; and (b) an activator domain that detectably modulates tissue regeneration.
Inventors:
Ulric Nielsen
Thomas Wickham
Birgit Schobert
Brian Harms
Brian Ringhi
Matthew Ontham
Byron Delabare
Shawn M Lipou
Thomas Wickham
Birgit Schobert
Brian Harms
Brian Ringhi
Matthew Ontham
Byron Delabare
Shawn M Lipou
Application Number:
JP2019117073A
Publication Date:
November 10, 2021
Filing Date:
June 25, 2019
Export Citation:
Assignee:
Silver Creek Pharmaceuticals, Inc.
International Classes:
C07K19/00; A61K38/18; A61K38/19; A61K38/20; A61K38/22; A61K38/30; A61K39/395; A61K47/54; A61K47/56; A61K47/62; A61K47/68; A61P1/16; A61P1/18; A61P7/00; A61P9/00; A61P11/00; A61P13/12; A61P17/00; A61P19/02; A61P19/08; A61P25/00; A61P43/00; C12N15/62
Domestic Patent References:
| JP6822911B2 | ||||
| JP11504329A | ||||
| JP2010508845A | ||||
| JP2009504157A |
Attorney, Agent or Firm:
Norihito Yamao
Kenji Tomita
Fumio Inai
Manami Sasakura
Kenji Tomita
Fumio Inai
Manami Sasakura
Previous Patent: Memory device and its manufacturing method
Next Patent: Optical security device based on rotating surface
Next Patent: Optical security device based on rotating surface